AmerisourceBergen has added $50 million more to resolve a DOJ probe into sales of cancer meds, taking its total in the matter to $885 million.

Here's your pharma manufacturing news of note.

Pfizer is in a tug of war with several states that intend to use some of its drugs to carry out executions.

With a U.S. saline shortage intensifying, the FDA is getting Baxter preferential treatment in having power restored to saline plants in Puerto Rico.

B. Braun, one of three main saline suppliers, is closing a plant for maintenance, a move it acknowledges will make a bad supply situation worse.

Cardinal Health has agreed to sell its China business to Shanghai Pharma for $557 million in cash.

Merck and GSK are coping with hepatitis A vaccine shortages as the U.S. is experiencing deadly outbreaks.

With expansion projects coming to fruition at a Pfizer plant in Michigan, the company expects to hire 200 workers next year.